These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 975075

  • 1. Combined adriamycin and hyperthermia treatment of a murine mammary carcinoma in vivo.
    Overgaard J.
    Cancer Res; 1976 Sep; 36(9 pt.1):3077-81. PubMed ID: 975075
    [Abstract] [Full Text] [Related]

  • 2. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
    Overgaard J, Radacic MM, Grau C.
    Cancer Res; 1991 Jan 15; 51(2):707-11. PubMed ID: 1985787
    [Abstract] [Full Text] [Related]

  • 3. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo.
    Jordan A, Scholz R, Wust P, Fähling H, Krause J, Wlodarczyk W, Sander B, Vogl T, Felix R.
    Int J Hyperthermia; 1997 Jan 15; 13(6):587-605. PubMed ID: 9421741
    [Abstract] [Full Text] [Related]

  • 4. Histopathological changes in transplanted mouse mammary carcinoma following hyperthermia with or without radiation.
    Jo S, Hiraoka M, Akuta K, Nishimura Y, Furuta M, Takahashi M, Abe M.
    Jpn J Cancer Res; 1986 Nov 15; 77(11):1095-101. PubMed ID: 3098719
    [Abstract] [Full Text] [Related]

  • 5. Reduced adriamycin concentration in rat mammary tumors treated previously with hyperthermia.
    Wilke AV, Ausmus PL, Frazier DL.
    Radiat Res; 1993 Aug 15; 135(2):278-80. PubMed ID: 8367599
    [Abstract] [Full Text] [Related]

  • 6. 4'-Epi-doxorubicin and hyperthermia in a murine mammary carcinoma: influence of the dose and fractionation.
    Cividalli A, Danesi DT, Altavista P, Bonanni M, Persiani D, Segre L, Cruciani G.
    Anticancer Res; 1995 Aug 15; 15(3):739-43. PubMed ID: 7645951
    [Abstract] [Full Text] [Related]

  • 7. Response of mammary tumors of C3H/He mice to hyperthermia and bleomycin in vivo.
    Ma F, Hiraoka M, Jo S, Akuta K, Nishimura Y, Takahashi M, Abe M.
    Radiat Med; 1985 Aug 15; 3(4):230-3. PubMed ID: 2425397
    [Abstract] [Full Text] [Related]

  • 8. Effects of systemically administered bleomycin or adriamycin with local hyperthermia on primary tumor and lung metastases.
    Marmor JB, Kozak D, Hahn GM.
    Cancer Treat Rep; 1979 Aug 15; 63(8):1279-90. PubMed ID: 89906
    [Abstract] [Full Text] [Related]

  • 9. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM, Hanson AD, Volker KM, Vu HA, Sim BK, Fogler WE, Fortier AH.
    Clin Cancer Res; 2003 Oct 01; 9(12):4619-26. PubMed ID: 14555538
    [Abstract] [Full Text] [Related]

  • 10. Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia.
    Baba H, Stephens LC, Strebel FR, Siddik ZH, Newman RA, Ohno S, Bull JM.
    Cancer Res; 1991 Jul 01; 51(13):3568-77. PubMed ID: 1905199
    [Abstract] [Full Text] [Related]

  • 11. Ultrastructure of a murine mammary carcinoma exposed to hyperthermia in vivo.
    Overgaard J.
    Cancer Res; 1976 Mar 01; 36(3):983-95. PubMed ID: 1253186
    [Abstract] [Full Text] [Related]

  • 12. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
    Horsman MR, Christensen KL, Overgaard J.
    Int J Hyperthermia; 1989 Mar 01; 5(2):123-36. PubMed ID: 2926180
    [Abstract] [Full Text] [Related]

  • 13. The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay.
    Horsman MR, Overgaard J, Chaplin DJ.
    Acta Oncol; 1988 Mar 01; 27(6b):861-2. PubMed ID: 3233175
    [No Abstract] [Full Text] [Related]

  • 14. Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes.
    Huang SK, Stauffer PR, Hong K, Guo JW, Phillips TL, Huang A, Papahadjopoulos D.
    Cancer Res; 1994 Apr 15; 54(8):2186-91. PubMed ID: 8174126
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of antitumor effect of hyperthermia with glucose administration in murine mammary carcinoma.
    Akagi K, Aoki Y, Nasu R, Nagata K, Itagaki Y, Sawada S.
    Oncol Rep; 1999 Apr 15; 6(3):593-6. PubMed ID: 10203597
    [Abstract] [Full Text] [Related]

  • 16. Interaction of hyperthermia and photoradiation therapy.
    Waldow SM, Dougherty TJ.
    Radiat Res; 1984 Feb 15; 97(2):380-5. PubMed ID: 6229807
    [Abstract] [Full Text] [Related]

  • 17. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F, Stuart OA, Glehen O, Urano M, Sugarbaker PH.
    Cancer Chemother Pharmacol; 2006 Dec 15; 58(6):719-24. PubMed ID: 16614851
    [Abstract] [Full Text] [Related]

  • 18. Development of thermotolerance during fractionated hyperthermia in a solid tumor in vivo.
    Kamura T, Nielsen OS, Overgaard J, Andersen AH.
    Cancer Res; 1982 May 15; 42(5):1744-8. PubMed ID: 7066896
    [Abstract] [Full Text] [Related]

  • 19. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
    Lehman CM, Stewart JR.
    Radiat Res; 1983 Dec 15; 96(3):628-34. PubMed ID: 6657927
    [Abstract] [Full Text] [Related]

  • 20. Distribution of adriamycin in mice under conditions of local hyperthermia which improve systemic drug therapy.
    Magin RL, Cysyk RL, Litterst CL.
    Cancer Treat Rep; 1980 Dec 15; 64(2-3):203-10. PubMed ID: 7407753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.